Literature DB >> 8569530

Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.

T Ohyama1, T Watanabe, Y Fujinaga, K Inoue, H Sunagawa, N Fujii, K Inoue, K Oguma.   

Abstract

A 9.8-kbp DNA fragment which contained a neurotoxin gene and its upstream region was cloned from Clostridium botulinum type D strain CB-16. Nucleotide sequencing of the fragment revealed that genes encoding for hemagglutinin (HA) subcomponents and one for a nontoxic-nonhemagglutinin (NTNH) component were located upstream of the neurotoxin gene. This strain produced two toxins of different molecular size (approximately 300 kDa and 500 kDa) which were designated as progenitor toxins (M and L toxins). The molecular size of the NTNH component of L toxin was approximately 130 kDa on SDS-PAGE and its N-terminal amino acid sequence was M-D-I-N-D-D-L-N-I-N-S-P-V-D-N-K-N-V-V-I which agreed with that deduced from the nucleotide sequence. In contrast, the M toxin had a 115-kDa NTNH component whose N-terminal sequence was S-T-I-P-F-P-F-G-G-Y-R-E-T-N-Y-I-E, corresponding to the sequence from Ser141 of the deduced sequence. A 15-kDa fragment, which was found to be associated with an M toxin preparation, possessed the same N-terminal amino acid sequence as that of the 130-kDa NTNH component. Furthermore, five major fragments generated by limited proteolysis with V8 protease were shown to have N-terminal amino acid sequences identical to those deduced from the nucleotide sequence of 130-kDa NTNH. These results indicate that the 130-kDa NTNH of the L toxin is cleaved at a unique site, between Thr and Ser, leading to the 115-kDa NTNH of the M toxin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569530     DOI: 10.1111/j.1348-0421.1995.tb02229.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.

Authors:  Hideyuki Arimitsu; Kaoru Inoue; Yoshihiko Sakaguchi; Jaechul Lee; Yukako Fujinaga; Toshihiro Watanabe; Tohru Ohyama; Robert Hirst; Keiji Oguma
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Crystallization and preliminary X-ray analysis of the Clostridium botulinum type D nontoxic nonhaemagglutinin.

Authors:  Keita Miyata; Ken Inui; Shin-Ichiro Miyashita; Yoshimasa Sagane; Kimiko Hasegawa; Takashi Matsumoto; Akihito Yamano; Koichi Niwa; Toshihiro Watanabe; Tohru Ohyama
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-27

3.  Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947.

Authors:  Kimiko Hasegawa; Toshihiro Watanabe; Hiroaki Sato; Yoshimasa Sagane; Shingo Mutoh; Tomonori Suzuki; Akihito Yamano; Hirokazu Kouguchi; Kouichi Takeshi; Arihide Kamaguchi; Yukako Fujinaga; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

4.  Reversible Association of the Hemagglutinin Subcomplex, HA-33/HA-17 Trimer, with the Botulinum Toxin Complex.

Authors:  Yoshimasa Sagane; Shingo Mutoh; Ryosuke Koizumi; Tomonori Suzuki; Shin-Ichiro Miyashita; Keita Miyata; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

5.  Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.

Authors:  Tomonori Suzuki; Thomas Nagano; Koichi Niwa; Masataka Uchino; Motohiro Tomizawa; Yoshimasa Sagane; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2016-10-26       Impact factor: 2.188

6.  TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR.

Authors:  J C Marvaud; U Eisel; T Binz; H Niemann; M R Popoff
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.

Authors:  Keita Miyata; Yoshimasa Sagane; Ken Inui; Shin-Ichiro Miyashita; Tomonori Suzuki; Keiji Oguma; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

8.  Molecular composition of Clostridium botulinum type A progenitor toxins.

Authors:  K Inoue; Y Fujinaga; T Watanabe; T Ohyama; K Takeshi; K Moriishi; H Nakajima; K Inoue; K Oguma
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Authors:  Tomonori Suzuki; Hirokazu Kouguchi; Toshihiro Watanabe; Kimiko Hasegawa; Tohru Yoneyama; Koichi Niwa; Atsushi Nishikawa; Jae-Chul Lee; Keiji Oguma; Tohru Ohyama
Journal:  Protein J       Date:  2007-04       Impact factor: 4.000

10.  Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity.

Authors:  Kwangkook Lee; Shenyan Gu; Lei Jin; Thi Tuc Nghi Le; Luisa W Cheng; Jasmin Strotmeier; Anna Magdalena Kruel; Guorui Yao; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.